TCS AI Growth Sparks Rally: Latest Price Targets Revealed

By: Anshul

On: December 18, 2025 1:26 PM

TCS shares chart showing AI growth rally and latest analyst price targets
Google News
Follow Us

TCS AI growth just hit a massive milestone, clocking $1.5 billion in annualized revenue from over 5,500 live projects – and it’s growing 16% quarter-on-quarter, outpacing the rest of the business. Shares jumped as investors cheered the disclosure, with brokerages like Motilal Oswal slapping on bullish targets up to ₹4,400. If you’re watching India’s IT powerhouse, this could signal your next portfolio move.

Key Highlights:

  • $1.5B AI revenue annualized, up 16% QoQ – fastest-growing segment.
  • Over 5,500 AI projects live across clients, spanning GenAI to custom solutions.
  • TCS share price gained ~2% post-disclosure, trading around ₹4,200.
  • Massive scale-up: 142,000 employees trained in AI, new data centers in key markets.
  • CEO eyes “world’s largest AI-led tech services company” status.

TCS’s AI Momentum

You’re probably wondering how TCS pulled this off amid a tricky IT slowdown. The secret? Relentless execution. They’ve baked AI adoption into everything – from cloud migrations to bespoke GenAI apps for Fortune 500 clients. K Krithivasan, CEO, highlighted this in recent earnings:

“TCS’s AI momentum positions it to become the world’s largest AI-led tech services company.” – TCS Official Press Release

This isn’t hype. TCS Q2 results show AI leading the charge while traditional services stabilize. They’ve invested big in data centers across Europe and the US, training a whopping 142,000 staff on AI tools. For you as an investor or tech follower, it means TCS isn’t just riding the IT sector AI boom – it’s steering it.

Analyst Price Targets

Brokerages are loving this TCS AI growth story. Here’s a quick breakdown of fresh calls:

BrokerageRatingTarget PriceUpside from ₹4,200
Motilal OswalBUY₹4,400~5%
EmkayADD₹4,300~2.5%
NuvamaBUY₹4,350~4%

These targets bake in AI as a key rerating catalyst. But what does this mean for your portfolio? If TCS nails global AI leadership, that 15%+ upside over 12 months looks realistic – especially versus peers lagging in GenAI deals.

Link to more insights: Check out the best AI tools for stock research to track these moves yourself.

Market Impact

TCS stock rally reflects broader confidence. Shares outperformed the Nifty IT index
TCS stock rally reflects broader confidence. Shares outperformed the Nifty IT index

TCS stock rally reflects broader confidence. Shares outperformed the Nifty IT index by 1.5% on the news, hitting a fresh 52-week high. Compared to Accenture or Infosys, TCS leads in AI project volume – a moat that’s hard to breach. Yet, some caution lingers: global spending softness could cap gains short-term.

For everyday investors like you, the real question is: Is TCS your hedge against AI disruption? With IT industry news updates showing peers scramble, TCS’s head start could deliver steady dividends plus growth.

What’s Next for TCS?

Picture this: TCS as the go-to AI factory for enterprises worldwide. Next quarter, watch for deal wins in GenAI verticals like healthcare and finance. TCS CEO K Krithivasan bets on scaling to $10B+ AI revenue in 3-5 years. If you’re allocating to tech, does this AI projects TCS scale tip the scales?

Conclusion

TCS AI growth isn’t a blip – it’s a transformation reshaping India’s IT bellwether into an AI juggernaut, with shares poised for more upside on those juicy price targets. This positions TCS ahead of the pack, but execution will be key.

What are your thoughts on this TCS share price surge? Will AI fuel a multi-bagger, or is caution warranted? Share your perspective in the comments below.

Anshul

Anshul, founder of Aicorenews.com, writes about Artificial Intelligence, Business Automation, and Tech Innovations. His mission is to simplify AI for professionals, creators, and businesses through clear, reliable, and engaging content.
For Feedback - admin@aicorenews.com

Join WhatsApp

Join Now

Join Telegram

Join Now

Leave a Comment